Bestaande gebruiker? Log in
Abonneren
Home
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Analisten vandaag
Meest aanbevolen aandelen
Minst aanbevolen aandelen
Aandelen met grootste potentieel
Insider trading
Insiders vandaag
Meest gekochte aandelen
Meest verkochte aandelen
Mijn Trivano
Mijn Trivano
Mijn selecties
Mijn nieuwsbrieven
Abonneren
Beurs vandaag
Koersen
Nieuws
Agenda
Analisten
Insider trading
Mijn Trivano
Registreren / inloggen
Beurs vandaag
Europa
Dexcom Inc
Nieuws
Dexcom Inc
DC4
XET
: DC4
| ISIN: US2521311074
12/11/2024
65,94 EUR
(-1,79%)
(-1,79%)
12/11/2024
Aandeel volgen
Aandeel gevolgd
Samenvatting
Nieuws
Insiders
Technische analyse
TA
Toon enkel gratis nieuws
11 september 2024 ·
Kessler Topaz Meltzer & Check, LLP Reminds DXCM Investors of October 21, 2024 Deadline in Securities Fraud Class Action and Urges Investors with Losses to Contact the Firm
· Persbericht
10 september 2024 ·
Shareholders that lost money on DexCom, Inc.(DXCM) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
· Persbericht
7 september 2024 ·
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit
· Persbericht
6 september 2024 ·
Investors who lost money on DexCom, Inc.(DXCM) should contact Levi & Korsinsky about pending Class Action - DXCM
· Persbericht
6 september 2024 ·
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DexCom
· Persbericht
5 september 2024 ·
DexCom, Inc. (DXCM) Investors: October 21, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
· Persbericht
3 september 2024 ·
Investors who lost money on DexCom, Inc.(DXCM) should contact Levi & Korsinsky about pending Class Action - DXCM
· Persbericht
27 augustus 2024 ·
Levi & Korsinsky Reminds DexCom, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024 - DXCM
· Persbericht
24 augustus 2024 ·
Class Action Announcement for Dexcom, Inc. (DXCM): Kessler Topaz Meltzer & Check, LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Dexcom, Inc.
· Persbericht
23 augustus 2024 ·
DexCom, Inc. Class Action: Levi & Korsinsky Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024 - DXCM
· Persbericht
21 augustus 2024 ·
Dexcom Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages DexCom, Inc. (NASDAQ: DXCM) Investors with Significant Losses to Contact the Firm
· Persbericht
14 augustus 2024 ·
DXCM Notice of Investigation: Kessler Topaz Meltzer & Check, LLP Encourages DexCom, Inc. (NASDAQ: DXCM) Investors with Significant Losses to Contact the Firm
· Persbericht
7 augustus 2024 ·
DexCom Investigation Notice: Kessler Topaz Meltzer & Check, LLP Encourages DexCom, Inc. (NASDAQ: DXCM) Investors with Significant Losses to Contact the Firm
· Persbericht
31 juli 2024 ·
DXCM Investigation Notice: Kessler Topaz Meltzer & Check, LLP Encourages DexCom, Inc. (NASDAQ: DXCM) Investors with Significant Losses to Contact the Firm
· Persbericht
29 juli 2024 ·
Bedrijfsnieuws uit Amerika
· Bolero.be
Apple moet AI-features in iOS 18 uitstellen De iPhone-maker Apple zal de artificiële intelligentie-functies niet klaar krijgen tegen de lancering van iOS 18, samen met de release van de nieuwe iPhone in september. De release...
28 juli 2024 ·
Edelson Lechtzin LLP Announces Investigation Dexcom, Inc. (NASDAQ: DXCM) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
· Persbericht
27 oktober 2023 ·
Thinking about buying stock in Bitfarms, Mullen Automotive, SeaStar Medical Holding, NKGen Biotech, or DexCom?
· Persbericht
Aandeel volgen
Aandeel gevolgd
Mijn selecties
Voorbeeldselectie
Je selectie is nog leeg.
Voeg nu effecten toe